Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Study of Oasis Ultra in Diabetic Foot Ulcers

ClinicalTrials.gov ID: NCT01835379

Public ClinicalTrials.gov record NCT01835379. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 10:56 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Open Label Controlled Trial of OASIS® Ultra Tri-Layer Matrix Compared to Standard Care in the Healing of Diabetic Foot Ulcers

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Many people with diabetes will develop a non-healing diabetic foot ulcer. Many ways are available to try to get a diabetic foot ulcer to heal, including application of Oasis Ultra. The hypothesis to be tested is that application of Oasis Ultra will cause more diabetic foot ulcers to heal than wounds treated with regular medical care. Subjects will have their diabetic foot wounds treated for up to 12 weeks with Oasis Ultra or regular medical care .

Study identification

NCT ID
NCT01835379
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Healthpoint
Industry
Enrollment
82 participants

Conditions and interventions

Interventions

Device · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2013 (Type not available)
Primary completion
Sep 2014 (Actual)
Completion
Sep 2014 (Actual)
Last update posted
Jan 22, 2015

2013 – 2014

United States locations

U.S. sites
16
U.S. states
9
U.S. cities
15
Facility City State ZIP Site status
Not listed Little Rock Arkansas 72205 —
Not listed Carlsbad California 92009 —
Not listed Fair Oaks California 95628 —
Not listed Fresno California 93720 —
Not listed San Diego California 92103 —
Not listed Evansville Indiana 47713 —
Not listed Madisonville Kentucky 42431 —
Not listed Shreveport Louisiana 71101 —
Not listed Saginaw Michigan 48602 —
Not listed Bayonne New Jersey 07002 —
Not listed Dallas Texas 75224 —
Not listed Dallas Texas 75243 —
Not listed Fort Worth Texas 76104 —
Not listed Houston Texas 77036 —
Not listed McAllen Texas 78501 —
Not listed Virginia Beach Virginia 23464 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01835379, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 22, 2015 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01835379 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →